| Literature DB >> 33369848 |
Anja Nitzsche1, Riikka Pietilä1, Dominic T Love1, Chiara Testini1, Takeshi Ninchoji1, Ross O Smith1, Elisabet Ekvärn1, Jimmy Larsson1, Francis P Roche1, Isabel Egaña1, Suvi Jauhiainen1, Philipp Berger2, Lena Claesson-Welsh1, Mats Hellström1.
Abstract
Cell signalling governs cellular behaviour and is therefore subject to tight spatiotemporal regulation. Signalling output is modulated by specialized cell membranes and vesicles which contain unique combinations of lipids and proteins. The phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2 ), an important component of the plasma membrane as well as other subcellular membranes, is involved in multiple processes, including signalling. However, which enzymes control the turnover of non-plasma membrane PI(4,5)P2 , and their impact on cell signalling and function at the organismal level are unknown. Here, we identify Paladin as a vascular PI(4,5)P2 phosphatase regulating VEGFR2 endosomal signalling and angiogenesis. Paladin is localized to endosomal and Golgi compartments and interacts with vascular endothelial growth factor receptor 2 (VEGFR2) in vitro and in vivo. Loss of Paladin results in increased internalization of VEGFR2, over-activation of extracellular regulated kinase 1/2, and hypersprouting of endothelial cells in the developing retina of mice. These findings suggest that inhibition of Paladin, or other endosomal PI(4,5)P2 phosphatases, could be exploited to modulate VEGFR2 signalling and angiogenesis, when direct and full inhibition of the receptor is undesirable.Entities:
Keywords: Paladin; VEGFR2; endocytosis; phosphatase; phosphoinositide
Mesh:
Substances:
Year: 2020 PMID: 33369848 PMCID: PMC7857541 DOI: 10.15252/embr.202050218
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807